Zeto Funding: How Much Did They Raise & Key Investors

How Much Did Zeto Raise?
Funding & Key Investors

Zeto, Inc., a Santa Clara-based pioneer in medical technology, has successfully secured a major strategic investment, bringing its total capital infusion to $38.3M. This latest financing round, which contributed $31M to the company's balance sheet, underscores the growing market confidence in Zeto's mission to modernize electroencephalography (EEG) diagnostics. By bridging the gap between traditional clinical procedures and 21st-century digital infrastructure, the firm is positioning itself as a critical player in the neurological monitoring landscape.

The company's growth trajectory has been marked by a steady accumulation of resources, starting with its initial Series A round in 2020 and culminating in this significant Series B milestone. This capital injection serves as a testament to the scalability of Zeto's FDA-cleared headset and cloud-based platform, which are designed to streamline brain activity monitoring for a wide array of conditions, including epilepsy, stroke, and sleep disorders.

What is Zeto?

Zeto

Manufacturing

Medical Devices & Equipment

Healthcare Software

Zeto, Inc. operates at the intersection of hardware engineering and cloud-based software to redefine how hospitals and clinics conduct EEG procedures. By replacing cumbersome, legacy equipment with a streamlined, noninvasive headset, Zeto enables real-time, high-fidelity monitoring of the brain's electrical activity. This technological shift is essential for improving diagnostic accuracy and patient outcomes in complex neurological cases. The company's platform is not merely a diagnostic tool but a comprehensive ecosystem that facilitates data-driven decision-making for clinicians, thereby reducing the operational friction typically associated with neurological assessments in acute care settings.

How much funding has Zeto raised?

Zeto has raised a total of $38.3M across 2 funding rounds:

2020

Series A

$7.3M

2025

Series B

$31M

Series A (2020): $7.3M with participation from Seraph Group, ShangBay Capital, SV Tech Ventures Inc, and Aphelion Capital LLC

Series B (2025): $31M led by Mindworks Global

Key Investors in Zeto

Mindworks Global

Mindworks Global specializes in bespoke AI-based content solutions and machine learning-driven services, providing strategic support for technology-forward enterprises.

Seraph Group

Seraph Group is a venture capital firm focused on identifying and supporting high-growth technology companies with disruptive potential.

ShangBay Capital

ShangBay Capital is a Palo Alto-based venture firm specializing in medical devices, biotechnology, and early-stage healthcare innovation.

What's next for Zeto?

With the successful closure of this major enterprise-level funding, Zeto is well-positioned to accelerate its commercial expansion and deepen its penetration into the global healthcare market. The strategic roadmap likely involves scaling manufacturing capabilities to meet rising demand and enhancing the analytical capabilities of its cloud platform through advanced machine learning integration. As the company continues to refine its noninvasive monitoring solutions, it is expected to play a pivotal role in the broader digital transformation of neurology, potentially setting new standards for how clinics manage and treat chronic brain-related conditions.

See full Zeto company page

See More Financial Insights